Circulating platelet products in unstable angina pectoris.

Area of Science:

• Cardiology
• Hematology
• Biochemistry

Background:

• Unstable angina pectoris is a critical manifestation of ischemic heart disease.
• The role of platelet activation in the pathophysiology of unstable angina requires further elucidation.

Purpose of the Study:

• To investigate the association between platelet activation markers and unstable angina pectoris.
• To explore the potential of measuring circulating platelet constituents for assessing therapeutic efficacy in ischemic heart disease.

Main Methods:

• Radioimmunoassay was used to measure plasma levels of platelet-derived proteins (beta-thromboglobulin, platelet factor 4) and thromboxane B2.
• Blood samples were collected from 19 patients with unstable angina at rest during anginal episodes and quiescent intervals.

Main Results:

• Significantly elevated plasma levels of beta-thromboglobulin and platelet factor 4 were observed during or within 4 hours after angina episodes.
• These platelet markers were typically normal during symptom-free periods.
• Plasma levels of thromboxane B2 showed a less clear relationship with angina, and fibrinopeptide A levels were not associated with angina.

Conclusions:

• Platelet activation and secretion are associated with unstable angina pectoris.
• Measuring circulating platelet constituents offers a novel approach for evaluating therapies in ischemic heart disease.
• Agents modulating platelet function should be considered for therapeutic trials in unstable angina patients.